Hepatitis C Vaccine Safe In Humans, Study Finds

TIME

The first human clinical trial of a new hepatitis C vaccine shows that it’s safe in humans, says a study published in the journal Science Translational Medicine. Researchers at the University of Oxford have shown that their first-of-its-kind vaccine for the transmissible liver disease is both effective and safe in an initial safety trial.

An estimated 3.2 million people in the U.S. have chronic hepatitis C, and most do not know they are infected because they don’t have visible or bothersome symptoms. Despite the emergence of effective (but pricey) drugs to treat hepatitis C in the last couple years, there’s still no vaccine. Other types of vaccines spur individuals’ bodies to create antibodies that fight a disease, but that hasn’t worked for hepatitis C. The new potential vaccine induces T cells that target several parts of the virus.

“Our lab spent many years looking at what happens with people…

View original post 176 more words

Advertisements
By aprilgaddis10

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s